MedPath

The effect of percutaneous electrical nerve stimulation on the respiratory outcomes of patients with Covid-19 with moderate pulmonary involvement

Not Applicable
Conditions
Covid-19.
Coronavirus disease (COVID-19)
U07.1
Registration Number
IRCT20210406050871N1
Lead Sponsor
Shahroud University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
84
Inclusion Criteria

Confirmation of Covid-19 diagnosis based on PCR test results or CT Scan findings (Ground Glass view) by physician
Age over 18 and under 70 years
Use the same treatment protocol for patients
Existence of moderate pulmonary involvement (SpO2 between 90 to 93% and pulmonary involvement less than 50%) and the patient being in the second phase of Covid-19 disease according to the guideline of the Ministry of Health

Exclusion Criteria

Drug addiction
Cigarette addiction
Advanced metastatic cancer
Congestive heart failure (grades 3 and 4)
Kidney failure requires dialysis
History of mechanical ventilation before intervention
Existence of cardiac pacemaker
Cardiac conduction disorders
History of allergies and skin sensitivities in the area of ??the electrodes
The presence of a skin lesion in the area where the electrodes are placed
Hospitalized patients with other clinical manifestations of Covid-19 and no pulmonary involvement
Continuous use of bronchodilators
Having liver failure
Moderate to severe scoliosis
Obesity (BMI above 35)
Psychological illnesses lead to lack of patient cooperation
Cerebrovascular disorders
Having COPD
Having uncontrolled diabetes
Inability and prohibition to be in a semi-sitting position for any reason

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath